Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Diversified Healthcare Trust (NASDAQ: DHC) closed at $2.63 in the last session, up 4.78% from day before closing price of $2.51. In other words, the price has increased by $4.78 from its previous closing price. On the day, 1.14 million shares were traded. DHC stock price reached its highest trading level at $2.67 during the session, while it also had its lowest trading level at $2.49.
Ratios:
We take a closer look at DHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.45 whereas as Long-Term Debt/Eq ratio is at 1.45.
Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 13 ’24 when Brown Matthew C. bought 2,000 shares for $2.55 per share. The transaction valued at 5,098 led to the insider holds 86,282 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 634553280 and an Enterprise Value of 3344572160. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 0.31. Its current Enterprise Value per Revenue stands at 2.264 whereas that against EBITDA is 15.512.
Stock Price History:
The Beta on a monthly basis for DHC is 2.17, which has changed by -0.027131796 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $4.24, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is 12.11%, while the 200-Day Moving Average is calculated to be -9.37%.
Shares Statistics:
According to the various share statistics, DHC traded on average about 1.14M shares per day over the past 3-months and 1065160 shares per day over the past 10 days. A total of 241.28M shares are outstanding, with a floating share count of 216.23M. Insiders hold about 10.38% of the company’s shares, while institutions hold 75.14% stake in the company. Shares short for DHC as of 1736899200 were 7047569 with a Short Ratio of 6.17, compared to 1734048000 on 7956266. Therefore, it implies a Short% of Shares Outstanding of 7047569 and a Short% of Float of 3.2399999999999998.
Dividends & Splits
The forward annual dividend rate for DHC is 0.04, which was 0.04 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.015936255The stock’s 5-year Average Dividend Yield is 3.31.
Earnings Estimates
A comprehensive evaluation of Diversified Healthcare Trust (DHC) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.25 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$1.47 and -$1.47 for the fiscal current year, implying an average EPS of -$1.47. EPS for the following year is -$0.92, with 1.0 analysts recommending between -$0.92 and -$0.92.
Revenue Estimates
According to 2 analysts, the current quarter’s revenue is expected to be $370.97M. It ranges from a high estimate of $374.3M to a low estimate of $367.64M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $361.54MFor the next quarter, 2 analysts are estimating revenue of $374.17M. There is a high estimate of $394.5M for the next quarter, whereas the lowest estimate is $353.84M.
A total of 2 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.49B, while the lowest revenue estimate was $1.48B, resulting in an average revenue estimate of $1.49B. In the same quarter a year ago, actual revenue was $1.41BBased on 2 analysts’ estimates, the company’s revenue will be $1.55B in the next fiscal year. The high estimate is $1.67B and the low estimate is $1.43B.
